[1]
H. Gordan, M. R. . Beyranvand, M. . Sheibani, M. Asadpur Piranfar, and M. A. . Pourhoseingholi, “Cost Effectiveness of Rivaroxaban versus Warfarin to Prevent Stroke in Iranian AF Patients”, Sch Med Stud J, vol. 2, no. 3, pp. 18–24, Sep. 2020.